Trial no.:
|
PACTR202404852537141 |
Date of Approval:
|
30/04/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
LIVEX PROJECT |
Official scientific title |
Improving physical and mental well-being of persons affected by NTDs: a 4-arm cluster-randomized trial. |
Brief summary describing the background
and objectives of the trial
|
The World Health Organization (WHO) estimates that mental disorders (especially depression and anxiety disorders) will be the highest cause of disease burden by 2030. WHO declares that, “The world is accepting the concept of universal health coverage (UHC). Mental health must be an integral part of UHC. Nobody should be denied access to mental health care because she or he is poor or lives in a remote place.” WHO estimates that by 2023, universal health coverage (UHC) will ensure access to quality and affordable care for mental health conditions in 12 priority countries to 100 million more people. In Nigeria, neglected tropical diseases (NTDs) including leprosy, lymphatic filariasis (LF) and Buruli ulcer (BU) co-exist in many states and are often associated with high levels of stigma and discrimination owing to their tendency to cause visible deformities. Over time, stigma and discrimination negatively impact the well-being and mental health of persons with these diseases resulting especially in depression, anxiety disorders or even suicidal ideation. The Country NTD Master Plan 2021-2025 and the Neglected Tropical Diseases (NTD), Nigeria multi-year Master Plan both described the need to focus on reducing morbidity, disability and mortality due to NTDs using integrated and cost-effective approaches.
Mental health services in Nigeria are deficient in quantity and quality. It is estimated that there is currently one psychiatrist to one million inhabitants and 40:1,000,000 for psychiatric nurses. Furthermore, distribution of the available professionals is grossly skewed in favour of urban areas.
This study is designed to ascertain the effectiveness, acceptability and feasibility of providing both mental health and self-care interventions in an integrated approach to improve quality of life and social inclusion as well as reduce disability and cost of healthcare by families affected by leprosy, Buruli ulcer (BU) and lymphatic filariasis (LF). |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Infections and Infestations,Mental and Behavioural Disorders,Skin and Connective Tissue Diseases |
Sub-Disease(s) or condition(s) being studied |
Leprosy, Buruli Ulcer and Lymphatic Filariasis |
Purpose of the trial |
Supportive care |
Anticipated trial start date |
01/10/2022 |
Actual trial start date |
01/10/2022 |
Anticipated date of last follow up |
31/03/2024 |
Actual Last follow-up date |
30/06/2024 |
Anticipated target sample size (number of participants) |
200 |
Actual target sample size (number of participants) |
238 |
Recruitment status |
Completed |
Publication URL |
|
|